The cost of chemotherapy for a brain tumor in Spain typically ranges from $8,000 to $16,000. Prices depend on the chemotherapy protocol, number of cycles, medication brands, and whether treatment is inpatient or outpatient. The clinic’s location and oncologist’s experience also impact costs. In the United States, the average cost is $30,000 (according to the American Cancer Society). Chemotherapy for a brain tumor in Spain is about 60% less than in the U.S.
Spanish hospitals usually include oncologist consultations, chemotherapy drugs, infusion sessions, routine bloodwork, and basic supportive medications in the price. In the U.S., drug costs, infusion fees, and lab tests are often billed separately, and supportive care can add extra charges. Always confirm exactly what each clinic’s quote covers before starting treatment.
| Turkey | Austria | Spain | |
| Chemotherapy for Brain Tumor | from $1,000 | from $12,000 | from $8,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Chemotherapy for Brain Tumor upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Chemotherapy for Brain Tumor and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Chemotherapy for Brain Tumor journey.
SJD Barcelona Children's Hospital (Spain) treats patients from infancy to 18 years old. It is among the top three medical institutions in Europe and a leading center for pediatric oncology. The hospital has a dedicated Laboratory for Molecular Medicine, where innovative treatment methods are developed.
Clinica Universidad de Navarra (CUN) is the best private Spanish hospital in 2018 according to MERCO (monitoring organization of medical reputation).
Navarra is a leading sarcoma center. 74% of patients get cured of bone sarcoma; and in up to 95% of cases, an affected limb is preserved.
Oncology, Onco-Hematology, Organ Transplant, Neurosurgery, Cardiac Surgery are the primary specialties in Navarra Hospital.
Hospital de Navarra is the 1st in Spain that has received JCI, the US certificate for the high quality of medical services.
Over 700,000 patients from 70 countries have been treated at Navarra.
Clinic HM Nou Delfos is a comprehensive medical-surgical center in Barcelona, which is a part of the largest network in Spain – HM Hospitals. HM Delfos specializes in surgery, oncology, orthopedics, cardiology, gynecology, urology, neurology including diagnosis and treatment of epilepsy. The clinic is equipped with the very latest devices for diagnostics and treatment: EOS for high-precision images of the musculoskeletal system, CT and MRI, two units for radiotherapy of tumors without surgery.
The clinic has also the agreement with Institut Guttmann, neurorehabilitation hospital with JCI, AQU Catalunya, and ISO quality certificates for rehabilitation.
GenesisCare is network of clinics specialized in high technology radiotherapy and chemotherapy. The network includes 300 clinics located in Australia, USA, Spain, UK and China. GenesisCare specialists treat all types of cancer in clinics equipped by latest generations machines for external beam radiotherapy, tomotherapy, CyberKnife, brachytherapy etc.
Day 1: Arrival
Day 2-3: Pre-operation
Day 4-5: Chemotherapy for Brain Tumor
Day 6: Post-operation
Week 1-2: Rehabilitation
Week 3: Return to Normal Activities
Week 4: Final Result
Please note that the timeline and process can vary depending on individual circumstances and the specifics of the brain tumor. Always consult with your healthcare team for advice tailored to your situation.
Dr. Francesc Graus is a neurologist with expertise in paraneoplastic neurological syndromes, gliomas, and primary brain lymphomas. He established the first strict diagnostic criteria for paraneoplastic syndromes. He also identified important antibodies that are now used in diagnosis. His research showed the link between tumors and autoimmune neurological attacks.
Dr. Graus earned his MD and PhD from Universitat Autònoma de Barcelona. He completed his neurology residency in Barcelona and a neuro-oncology fellowship at Memorial Sloan-Kettering Cancer Center. He is an Emeritus investigator at IDIBAPS. He founded and served as president of the European Association of Neuro-Oncology. He is also the former chief of neurology at Hospital Clinic Barcelona.